Replies to post #24372 on BioSante Pharmaceuticals, Inc. (BPAX)

[Winalov]

Rg, It is a valid question. I can tell you the way I see it.
I don't say NO just to be the pain in the ass. Since the merger agreement is still not complete, negotiations are not over. If both sides are this close to reach the consensus, maybe sweeten the deal up for BPAX SH a little bit would be easier to swallow. Scrap RS, make the ratio 50 : 50. If comes to new BOD? 3:4 would put ANI possibly more capable people in charge.
I'll vote for this.

[rgshredder]

Let's say the merger passes...let's also say that shortly thereafter, TEVA announces production of biot to be manufactured by ANI/bpax...what type of market response would one expect with that...pps effect?

also, never got a response to my previous post.
-RG